All PlansCoverageMedium impact
Adipose-Derived Stem Cells in Autologous Fat Grafting to the Breast
Blue Cross & Blue Shield of Mississippi·MS · Plastic Surgery, General Surgery, Oncology·Medical Policy
Effective date
Mar 19, 2025
We identified it
Jun 20, 2026
Summary
This policy confirms that adipose-derived stem cells (ADSCs) used in autologous fat grafting to the breast remain considered investigational and are not covered. The policy was reviewed with no changes on March 19, 2025, maintaining the existing coverage determination that these procedures are experimental.
Action Required
Immediately: Billing team must ensure claims for adipose-derived stem cells in breast fat grafting are not submitted, as these procedures are considered investigational and will be denied. Use CPT 19499 (unlisted breast procedure) only for documentation purposes. Providers should inform patients this is not a covered benefit.